We investigate the discrete Fuglede's conjecture and Pompeiu problem on finite abelian groups and develop a strong connection between the two problems. We give a geometric condition under which a multiset of a finite abelian group has the discrete Pompeiu property. Using this description and the revealed connection we prove that Fuglede's conjecture holds for Z p n q 2 , where p and q are different primes. In particular, we show that every spectral subset of Z p n q 2 tiles the group. Further, using our combinatorial methods we give a simple proof for the statement that Fuglede's conjecture holds for Z 2 p .
We investigate the functional equation n i=1 a i f (b i x + c i y) = 0, where a i , b i , c i ∈ C, and the unknown function f is defined on the field K = Q(b 1 , . . . , b n , c 1 , . . . , c n ). (It is easy to see that every solution on K can be extended to C as a solution.) Let S 1 denote the set of additive solutions defined on K. We prove that S 1 is spanned by S 1 ∩ D, where D is the set of the functions φ • D, where φ is a field automorphism of C and D is a differential operator on K. We say that the equation We show that S is spanned by S ∩ A, where A is the algebra generated by D. This implies that if S is translation invariant, then spectral synthesis holds in S. The main ingredient of the proof is the observation that if V is a variety on the Abelian group (K * ) k under multiplication, and every function F ∈ V is k-additive on K k , then spectral synthesis holds in V .We give several applications, and describe the set of solutions of equations having some special properties (e.g. having algebraic coefficients etc.).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.